Top

Published in:

Open Access 01-12-2012 | Research article

Detection of helicobacter pylori in benign laryngeal lesions by polymerase chain reaction: a cross sectional study

Authors: Farzad Izadi, Aslan Ahmadi, Shadi Ghourchian, Ahmad Daneshi, Faramarz Memari, Ehsan Khadivi, Shabahang Mohammadi

Published in: Infectious Agents and Cancer | Issue 1/2012

Abstract

Background

Although Helicobacter Pylori (HP) was detected in some cases of chronic laryngitis, the results were not confirmed by polymerase chain reaction (PCR). By this time, it has not been found in laryngeal lesions by in house PCR, the most sensitive method for detecting the genome tracks. Regarding the previous results and also few numbers of studies about the presence of HP in benign laryngeal lesions, specifically by PCR, we aimed to investigate the presence of HP in benign laryngeal lesions by in-house PCR.

Methods

The samples were taken from 55 patients with benign laryngeal lesions and frozen in −20°C. One milliliter (ml) of lysis buffer was added to 100 mg (mg) of each sample and the tube was placed in 56°C overnight. Then DNA extraction was carried out.

Results

To find HP DNA, in-house PCR was performed that revealed 5 positive results among 55 patients with benign laryngeal lesions. Of them, 3 were polyp, 1 was nodule and 1 was papilloma.

Conclusion

Although the number of positive results was not a lot in this study, it was in contrast with previous studies which could not find any HP tracks in benign laryngeal lesions by other methods. More studies about the prevalence of HP in benign laryngeal lesions improve judging about the effect of this infection on benign laryngeal lesions.

Available only for authorised users

André AR, Ferreira MV, Mota RM, Ferrasi AC, Pardini MI, Rabenhorst SH: Gastric adenocarcinoma and Helicobacter pylori: correlation with p53 mutation and p27 immunoexpression. Cancer Epidemiol. 2010, 34 (5): 618-625. 10.1016/j.canep.2010.05.005.PubMedCrossRef

Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M, Japan Gast Study Group, Japan Gast Study Group: Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008, 9636: 392-397.CrossRef

Dore-Davin C, Heitz M, Yang H, Herranz M, Blum AL, Corthesy-Theulaz I: Helicobacter pylori in the oral cavity reflects handling of contaminants but not gastric infection. Digestion. 1999, 60: 196-202. 10.1159/000007659.PubMedCrossRef

Nishimura M, Miyajima S, Okada N: Salivary gland MALT lymphoma associated with Helicobacter pylori infection in a patient with Sjögren’s Syndrome. J Dermatol. 2000, 27 (7): 450-452.PubMedCrossRef

Song Q, Lange T, Spahr A, Adler G, Bode G: Characteristic distribution pattern of helicobacter pylori in dental plaque and saliva detected with nested PCR. J Med Microbiol. 2000, 49: 349-353.PubMedCrossRef

Okuda K, Ishihara K, Miura T, Katakura A, Noma H, Ebihara Y: Helicobacter pylori may have only a transient presence in the oral cavity and on the surface of oral cancer. Microbiol Immunol. 2000, 44: 385-388.PubMedCrossRef

Wichelhaus A, Brauchli L, Song Q, Adler G, Bode G: Prevalence of Helicobacter pylori in the adolescent oral cavity: dependence on orthodontic therapy, oral flora and hygiene. J Orofac Orthop. 2011, 72 (3): 187-195. 10.1007/s00056-011-0024-5.PubMedCrossRef

Eskandari A, Mahmoudpour A, Abolfazli N, Lafzi A: Detection of Helicobacter pylori using PCR in dental plaque of patients with and without gastritis. Med Oral Patol Oral Cir Bucal. 2010, 15 (1): 28-31.

Goosen C, Theron J, Ntsala M, Maree FF, Olckers A, Botha SJ, Lastovica AJ, van der Merwe SW: Evaluation of a novel heminested PCR assay based on the phosphoglucosamine mutase gene for detection of Helicobacter pylori in saliva and dental plaque. J Clin Microbiol. 2002, 40 (1): 205-209. 10.1128/JCM.40.1.205-209.2002.PubMedPubMedCentralCrossRef

10.

Borkowski G, Sudhoff H, Koslowski F, Hackstedt G, Radu HJ, Luckhaupt H: A possible role of helicobacter pylori infection in the etiology of chronic laryngitis. Eur Arch Otorhinolaryngol. 1997, 254: 481-482. 10.1007/BF02439987.PubMedCrossRef

11.

Akbayir N, Basak T, Seven H, et al: Investigation of Helicobacter pylori colonization in laryngeal neoplasia. Eur Arch Otorhinolaryngol. 2005, 262: 170-172. 10.1007/s00405-004-0794-0.PubMedCrossRef

12.

Jaspersen D, Weber R, Diehl KL, Kind M, Arps H, Draf W: Ist die chronische Laryngitis Helicobacter-pylori -assoziiert? Ergebnisse einer prospektiven Studie. Z Gastroenterol. 1998, 36: 369-372.PubMed

13.

Megraud F, Lehours P: Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev. 2007, 20: 280-322. 10.1128/CMR.00033-06.PubMedPubMedCentralCrossRef

14.

Linke S, Lenz J, Gemein S, Exner M, Gebel J: Detection of Helicobacter pylori in biofilms by real-time PCR. Int J Hyg Environ Health. 2010, 213 (3): 176-182. 10.1016/j.ijheh.2010.03.006.PubMedCrossRef

15.

Mustafa Ozyurt, Atila Gungor, Koray Ergunay, Engin Cekin, Evren Erkul, Tuncer Haznedaroglu: Real-time PCR detection of Helicobacter pylori and virulence-associated cagA in nasal polyps and laryngeal disorders. Otolaryngol Head Neck Surg. 2009, 141: 131-135. 10.1016/j.otohns.2009.04.005.CrossRef

16.

Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Freidman GD: Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994, 330: 1267-1271. 10.1056/NEJM199405053301803.PubMedCrossRef

17.

Us D, Hascelik G: Seroprevalence of Helicobacter pylori infection in an asymptomatic Turkish population. J Infect. 1998, 37: 148-150. 10.1016/S0163-4453(98)80169-2.PubMedCrossRef

18.

Ulualp SO, Toohill RJ: Laryngopharyngeal reflux: state of art diagnosis and treatment. Otolaryngol Clin North Am. 2000, 33: 785-802. 10.1016/S0030-6665(05)70244-9.PubMedCrossRef

19.

Harrill WC, Stasney CR, Donovan DT: Laryngopharyngeal reflux: a possible risk factor in laryngeal and hypopharyngeal carcinoma. Otolaryngol Head Neck Surg. 1999, 120: 598-601.PubMed

20.

Kusters JG, van Vliet AHM, Kuipers EJ: Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006, 19: 449-490. 10.1128/CMR.00054-05.PubMedPubMedCentralCrossRef

21.

Ozdek A, Cirak MY, Samim E, et al: A possible role of Helicobacter pylori in chronic rhinosinusitis: a preliminary report. Laryngoscope. 2003, 113: 679-682. 10.1097/00005537-200304000-00018.PubMedCrossRef

22.

Titiz A, Ozcakir O, Ceyhan S, et al: The presence of Helicobacter pylori in the larynx pathologies. Auris Nasus Larynx. 2008, 35: 534-538. 10.1016/j.anl.2007.12.004.PubMedCrossRef

23.

Koc C, Arikan OK, Atasoy P, et al: Prevalence of Helicobacter pylori in patients with nasal polyps: a preliminary report. Laryngoscope. 2004, 114: 1941-1944. 10.1097/01.mlg.0000147924.96980.34.PubMedCrossRef

24.

Cirak MY, Ozdek A, Yilmaz D, et al: Detection of Helicobacter pylori and its CagA gene in tonsil and adenoid tissues by PCR. Arch Otolaryngol Head Neck Surg. 2003, 129: 1225-1229. 10.1001/archotol.129.11.1225.PubMedCrossRef

25.

Koufman JA: The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development laryngeal injury. Laryngoscope. 1991, 101: 1-78.PubMedCrossRef

26.

Batch AJG: Globus pharyngeus (Part 1). J Laryngol Otol. 1998, 102: 152-158.CrossRef

27.

Paterson WG: Extraesophageal complications of gastroesophageal reflux disease. Can J Gastroenterol. 1997, 11: 45B-50B.PubMed

28.

Salehi Z, Jelodar MH, Rassa M, Ahaki M, Mollasalehi H, Mashayekhi F: Helicobacter pylori cagA status and peptic ulcer disease in Iran. Dig Dis Sci. 2009, 54 (3): 608-613. 10.1007/s10620-008-0378-8.PubMedCrossRef

29.

Kizilay A, Saydam L, Aydin A: M. Tayyar Kalcioglu, Orhan Ozturan, N. Engin Aydin. Histopathologic Examination for Helicobacter pylori as a Possible Etiopathogenic Factor in Laryngeal Carcinoma. Chemotherapy. 2006, 52: 80-82. 10.1159/000091727.PubMedCrossRef

30.

Aygenc E, Selcuk A, Celikkanat S, Ozbek C, Ozdem C: The role of helicobacter pylori infection in the cause of squamous cell carcinoma of the larynx. Otolaryngol Head Neck Surgery. 2001, 125: 520-521.

31.

Rubin JS, Benjamin E, Prior A, Lavy J: The prevalence of helicobacter pylori infection in malignant and premalignant conditions of the head and neck. J Laryngol Otol. 2003, 117: 118-121.PubMedCrossRef

32.

Masoud N, Manouchehr K, Najmeh D, Monireh H: Lack of association between Helicobacter pylori and laryngeal carcinoma. Asian Pac J Cancer Prev Jan-Mar. 2008, 9 (1): 81-82.

33.

Grandis JR, Perez-Perez GI, Yu VL, Johnson JT, Blaser MJ: Lack of serologic evidence for helicobacter pylori infection in head and neck cancer. Head Neck. 1997, 19: 216-218. 10.1002/(SICI)1097-0347(199705)19:3<216::AID-HED9>3.0.CO;2-5.PubMedCrossRef

34.

Said RM, Cheah P-L, Chin S-C, Goh K-L: Evaluation of a new biopsy urease test: Pronto Dry, for the diagnosis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 2004, 16 (2): 195-199. 10.1097/00042737-200402000-00012.PubMedCrossRef

35.

Caletti G, Caletti G, Togliani T, Fusaroli P, et al: Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti–Helicobacter pylori therapy. Gastroenterol. 2003, 124: 537-543. 10.1053/gast.2003.50043.CrossRef

36.

Akbayir N, Basak T, Seven H, Sungun A, Erdem L: Investigation of Helicobacter pylori colonization in laryngeal neoplasia. Eur Arch Otorhinolaryngol. 2005, 262: 170-172. 10.1007/s00405-004-0794-0.PubMedCrossRef

37.

Bulut Y, Agacayak A, Karlidag T, et al: Association of cagA + Helicobacter pylori with adenotonsillar hypertrophy. Tohoku J Exp Med. 2006, 209: 229-233. 10.1620/tjem.209.229.PubMedCrossRef

Title: Detection of helicobacter pylori in benign laryngeal lesions by polymerase chain reaction: a cross sectional study
Authors: Farzad Izadi
Aslan Ahmadi
Shadi Ghourchian
Ahmad Daneshi
Faramarz Memari
Ehsan Khadivi
Shabahang Mohammadi
Publication date: 01-12-2012
Publisher: BioMed Central
Published in: Infectious Agents and Cancer / Issue 1/2012
Electronic ISSN: 1750-9378
DOI: https://doi.org/10.1186/1750-9378-7-10

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2012

Molecular chaperone therapy- the future in cancer

Role of chronic E. coli infection in the process of bladder cancer- an experimental study

HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies

Consistent condom use increases spontaneous regression in high-risk non-HPV16 but not in HPV16 CIN2-3 lesions, a prospective population-based cohort study

Peripheral blood lymphocytes from low-grade squamous intraepithelial lesions patients recognize vaccine antigens in the presence of activated dendritic cells, and produced high levels of CD8 + IFNγ + T cells and low levels of IL-2 when induced to proliferate

Prevalence of human papillomavirus in the cervical epithelium of Mexican women: meta-analysis

Keynote webinar | Spotlight on antibody–drug conjugates in cancer